From our data, UA was demonstrated to downregulate ING5 expression in a concentration- and time-dependent manner, with the same antitumor effects with ING5 knockdown, and ING5 silencing could weaken the effects of UA, suggesting that UA may serve as a targeted inhibitor of ING5 for HCC treatment. This evidence concerns the gene ING5 and hepatocellular carcinoma.